Equity Research, Broker Reports, and media content on Destiny Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Destiny Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Destiny Pharma Plc

Company Profile

  • Personnel
  • Neil Clark, CEO
  • Nick Rodgers, Chairman

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Destiny Pharma Plc. We currently have 72 research reports from 5 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 29.0/137p
  • Daily Volume: N/A
  • Daily Liquidity: (0%)
  • # Shares: 43.9m
  • Market Cap: £63.4m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
10Feb21 14:05 RNS Second Price Monitoring Extn
10Feb21 14:00 RNS Price Monitoring Extension
03Feb21 07:00 RNS Brazilian Patent Granted for XF-73 nasal gel
02Feb21 07:00 RNS Destiny Pharma Appoints Professor Mark Wilcox
21Jan21 16:41 RNS Second Price Monitoring Extn
21Jan21 16:35 RNS Price Monitoring Extension
21Jan21 16:31 RNS Grant of Share Options
  • Frequency of research reports


  • Research reports on

    Destiny Pharma Plc

  • Providers covering

    Destiny Pharma Plc